BDX Share Price Performance
AU$0
-0.10 (-100.00%)
Price AU$0
Share Pricen/a
BCAL Diagnostics Limited Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 1 Fair Values set on narratives written by author
BDX Community Narratives
There are no narratives available yet.
There are no community narratives available.
Snowflake Analysis
BCAL Diagnostics Limited Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- -0.02
- 100.00%
- -273.21%
- 27.3%
About BDX
- Founded
- 2010
- Employees
- n/a
- CEO
- WebsiteView website
BCAL Diagnostics Limited, a screening and diagnostic company, engages in developing a novel blood screening test to improve the diagnosis and monitoring of breast cancer. It develops BREASTESTplus, a first-in-class blood test designed to be used alongside standard mammogram in breast cancer screening. The company also develops BREASTEST, BCAL Diagnostics, and BCAL Dx. The company was incorporated in 2010 and is headquartered in Sydney, Australia.
